-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q4 2024.
- Coeptis Therapeutics Holdings, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$850K, a 118% decline year-over-year.
- Coeptis Therapeutics Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was -$823K, a 466% decline year-over-year.
- Coeptis Therapeutics Holdings, Inc. annual Nonoperating Income (Expense) for 2024 was -$823K, a 466% decline from 2023.
- Coeptis Therapeutics Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $225K.
- Coeptis Therapeutics Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.38M, a 666% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)